Young adults with elevated cholesterol often go untreated, study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jan-2026 15:11 ET (15-Jan-2026 20:11 GMT/UTC)
Fewer than half of young adults with severely high low-density lipoprotein (LDL-C), or “bad” cholesterol, levels start taking a statin within five years of first high LDL-C measurement, according to a study published in JACC, the flagship journal of the American College of Cardiology, and presented at the American Heart Association’s 2025 Scientific Sessions. The 2018 ACC/AHA Cholesterol Guideline recommends a statin in patients with LDL-C over 190 mg/dL and these findings highlight significant care gaps in lipid management among adults aged 18 to 39, particularly those at high risk for premature atherosclerotic cardiovascular disease (ASCVD).
A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.
That is the conclusion of a Rutgers-led study published in The Journal of Clinical Endocrinology & Metabolism, which found that metformin blunts critical improvements in blood vessel function, fitness and blood sugar control that normally come from working out.
UC San Diego researchers find that a weeklong mind-body retreat led to rapid changes in brain function and blood biology, boosting resilience, pain relief, and stress recovery—showing how meditation and related practices can quickly impact health.
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide. Low insulin levels allow glucose levels to remain elevated, which in the long term can damage organs such as the kidneys, the eyes, and the cardiovascular system. People with diabetes require lifelong monitoring of blood sugar levels coupled with insulin injections to keep blood sugar levels at a stable, healthy level.
A potential new treatment option for those patients is the replacement of lost or dysfunctional pancreatic beta cells, either by cell transplantation, or by the generation of new beta cells from existing cells within the body. This latter strategy was pursued by the team of Xiaofeng Huang from Weill Cornell Medicine, USA and Qing Xia from Peking University, China who previously discovered that cells in the mouse stomach can be transformed into pancreatic beta cells by genetic engineering.